Rivaroxaban Plus Aspirin Versus Acenocoumarol to Manage Recurrent Venous Thromboembolic Events Despite Systemic Anticoagulation With Rivaroxaban
Latest Information Update: 29 Aug 2022
At a glance
- Drugs Aspirin (Primary) ; Rivaroxaban (Primary) ; Acenocoumarol
- Indications Haemorrhage; Pulmonary embolism; Venous thromboembolism
- Focus Therapeutic Use
Most Recent Events
- 29 Aug 2022 New trial record